Xiang-zhou Zeng

发表

Sinomenine Suppresses Osteoclast Formation and Mycobacterium tuberculosis H37Ra-Induced Bone Loss by Modulating RANKL Signaling Pathways

Suiyi Tan, Jiake Xu, Yiping Hu, 2013, PloS one.

Aconine inhibits RANKL-induced osteoclast differentiation in RAW264.7 cells by suppressing NF-κB and NFATc1 activation and DC-STAMP expression

L. Tao, Long-gang He, Xiang-zhou Zeng, 2015, Acta Pharmacologica Sinica.

Artesunate attenuates LPS-induced osteoclastogenesis by suppressing TLR4/TRAF6 and PLCγ1-Ca2+-NFATc1 signaling pathway

Min Zou, Qin Yang, Bin-hua Zou, 2019, Acta Pharmacologica Sinica.

Sinomenine induces apoptosis in RAW 264.7 cell-derived osteoclasts in vitro via caspase-3 activation

Xianglian Li, L. Lei, Long-gang He, 2013, Acta Pharmacologica Sinica.

B‐cell‐specific‐peroxisome proliferator‐activated receptor γ deficiency augments contact hypersensitivity with impaired regulatory B cells

X. Bai, Xuan Zhou, L. Tao, 2019, Immunology.

Nanoparticles Delivering Antagomir-483-5p to Bone Marrow Mesenchymal Stem Cells Prevent Osteoporosis by Increasing Bone Formation

Yue Zhou, Xiang-zhou Zeng, A. Hu, 2021 .

Frugoside delays osteoarthritis progression via inhibiting miR-155-modulated synovial macrophage M1 polarisation.

Y. Liu, Haiyan Zhang, Hua Wang, 2021, Rheumatology.

Artesunate suppresses RANKL‐induced osteoclastogenesis through inhibition of PLC&ggr;1‐Ca2+–NFATc1 signaling pathway and prevents ovariectomy‐induced bone loss

Jiake Xu, Shuwen Liu, Min Zou, 2017, Biochemical pharmacology.